NeuroPace’s Aid in Tracking and Treating Epilepsy

NeuroPace’s Aid in Tracking and Treating Epilepsy

MPO's Sean Fenske speaks with Mike Favet of NeuroPace about a strategic partnership and what it means for those suffering from epilepsy.

By Sean Fenske, Editor-in-Chief02.22.22
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Mike Favet, CEO of NeuroPace. He offers insights into how his technology helps those suffering with epilepsy. In addition, he provides an explanation of the firm’s nSight Platform. Finally, he talks about the partnership with another organization focused on epilepsy and how it integrates with his firm’s technologies. Specifically, the following questions are addressed.

  • Can you please explain what the focus of your company NeuroPace is?
  • What is the nSight Platform and how does it lead to a better treatment protocol for patients with epilepsy?
  • Why have you partnered with Seizure Tracker?
  • With the three of these systems combined and working together, what is the impact to those with epilepsy?
  • What’s next for NeuroPace? What are the next steps?

Listen to this episode and see what you think of these epilepsy solutions. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Click here to review other podcasts.
Related Searches: